Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer

SIMPLE SUMMARY: Overactivation of the human epidermal growth factor receptor 2 (HER2) is one of the main drivers of tamoxifen resistance in estrogen receptor (ER)-positive breast cancer patients. Combined targeting of HER2 and ER, however, has yielded disappointing results in the clinical setting. T...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Menendez, Javier A., Papadimitropoulou, Adriana, Vander Steen, Travis, Cuyàs, Elisabet, Oza-Gajera, Bharvi P., Verdura, Sara, Espinoza, Ingrid, Vellon, Luciano, Mehmi, Inderjit, Lupu, Ruth
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961649/
https://ncbi.nlm.nih.gov/pubmed/33800852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051132
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items